The current treatments for<unk>  focus on relieving the symptoms. One treatment is a<unk> -behavioral therapy (CBT) technique that involves making the patient aware of their<unk>  problems. For example, many<unk>  patients struggle with multitasking. With CBT, the patient would have to be aware of this problem and focus on just one task at a time. This technique is also used to relieve some motor symptoms. In a case study with a patient who had a stroke and developed<unk> , improvements in mental function and attention were achieved through reality orientation therapy and attention process training. Reality orientation therapy consists of continually exposing the patient to stimuli of past events, such as photos. Attention process training consists of visual and auditory tasks that have been shown to improve attention. The patient struggled in applying these skills to “real-life” situations. It was the help of his family at home that significantly helped him regain his ability to perform activities of daily living. The family would motivate the patient to perform basic tasks and made a regular schedule for him to follow. Transcranial magnetic stimulation (TMS) has also been proposed to be a possible treatment of psychiatric disorders of the cerebellum. One study used TMS on the vermis of patients with schizophrenia. After stimulation, the patients showed increased happiness, alertness and energy, and decreased sadness. Neuropsychological testing post-stimulation showed improvements in working memory, attention, and visual spatial skill. Another possible method of treatment for<unk>  is doing exercises that are used to relieve the motor symptoms. These physical exercises have been shown to also help with the<unk>  symptoms. Medications that help relieve deficits in traumatic brain injuries in adults have been proposed as candidates to treat<unk> . Bromocriptine, a direct D2 agonist, has been shown to help with deficits in executive function and spatial learning abilities. Methylphenidate has been shown to help with deficits in attention and inhibition. Neither of these drugs has yet been tested on a<unk>  population. It may also be that some of the symptoms of<unk>  improve over time without any formal treatment. In the original report of<unk> , four patients with<unk>  were re-examined one to nine months after their initial neuropsychological evaluation. Three of the patients showed improvement in deficits without any kind of formal treatment, though executive function was still found to be one standard deviation below average. In one patient, the deficits worsened over time. This patient had cerebellar atrophy and worsened in visual spatial abilities, concept formation, and verbal memory. None of these treatments were tested on a large enough sample to determine if they would help with the general<unk>  population. Further research needs to be done on treatments for<unk> .
Cerebellar cognitive affective syndrome
Post-encephalitic parkinsonism
Dejerine–Roussy syndrome
Dopamine-responsive dystonia
Bickerstaff brainstem encephalitis
Wernicke–Korsakoff syndrome
Paraneoplastic cerebellar degeneration
Parkinson-plus syndrome